These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28583368)

  • 21. Mixed-lineage kinases: a target for the prevention of neurodegeneration.
    Wang LH; Besirli CG; Johnson EM
    Annu Rev Pharmacol Toxicol; 2004; 44():451-74. PubMed ID: 14744254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies.
    López González I; Garcia-Esparcia P; Llorens F; Ferrer I
    Int J Mol Sci; 2016 Feb; 17(2):206. PubMed ID: 26861289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutathione transferases and neurodegenerative diseases.
    Mazzetti AP; Fiorile MC; Primavera A; Lo Bello M
    Neurochem Int; 2015 Mar; 82():10-8. PubMed ID: 25661512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases.
    Pratt BM; McPherson JM
    Cytokine Growth Factor Rev; 1997 Dec; 8(4):267-92. PubMed ID: 9620642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropathology of cigarette smoking.
    Chang RC; Ho YS; Wong S; Gentleman SM; Ng HK
    Acta Neuropathol; 2014 Jan; 127(1):53-69. PubMed ID: 24240736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The olfactory vector hypothesis of neurodegenerative disease: is it viable?
    Doty RL
    Ann Neurol; 2008 Jan; 63(1):7-15. PubMed ID: 18232016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease.
    Clark IA; Vissel B
    Biochem Pharmacol; 2013 Oct; 86(7):862-71. PubMed ID: 23939185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases.
    Maruszak A; Gaweda-Walerych K; Sołtyszewski I; Zekanowski C
    Acta Neurobiol Exp (Wars); 2006; 66(2):153-76. PubMed ID: 16886726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eye movements in neurodegenerative diseases.
    MacAskill MR; Anderson TJ
    Curr Opin Neurol; 2016 Feb; 29(1):61-8. PubMed ID: 26641817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-arginine and nitric oxide in CNS function and neurodegenerative diseases.
    Virarkar M; Alappat L; Bradford PG; Awad AB
    Crit Rev Food Sci Nutr; 2013; 53(11):1157-67. PubMed ID: 24007420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting neuroplasticity in patients with neurodegenerative diseases using brain stimulation techniques.
    Yuan TF; Li WG; Zhang C; Wei H; Sun S; Xu NJ; Liu J; Xu TL
    Transl Neurodegener; 2020 Dec; 9(1):44. PubMed ID: 33280613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration.
    Vyas S; Rodrigues AJ; Silva JM; Tronche F; Almeida OF; Sousa N; Sotiropoulos I
    Neural Plast; 2016; 2016():6391686. PubMed ID: 27034847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease.
    Van Bulck M; Sierra-Magro A; Alarcon-Gil J; Perez-Castillo A; Morales-Garcia JA
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30743990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondria dysfunction and neurodegenerative disorders: cause or consequence.
    Morais VA; De Strooper B
    J Alzheimers Dis; 2010; 20 Suppl 2():S255-63. PubMed ID: 20463408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic potential of berberine against neurodegenerative diseases.
    Jiang W; Li S; Li X
    Sci China Life Sci; 2015 Jun; 58(6):564-9. PubMed ID: 25749423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking-associated protection from Alzheimer's and Parkinson's disease.
    Morens DM; Grandinetti A; Reed D; White LR
    Lancet; 1994 Feb; 343(8893):356-7. PubMed ID: 7695666
    [No Abstract]   [Full Text] [Related]  

  • 39. Ironic fate: can a banned drug control metal heavies in neurodegenerative diseases?
    Cole GM
    Neuron; 2003 Mar; 37(6):889-90. PubMed ID: 12670416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetics in neurodegeneration: a new layer of complexity.
    Marques SC; Oliveira CR; Pereira CM; Outeiro TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):348-55. PubMed ID: 20736041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.